ResearcherSichuan UniversityActive in the last 2 years
Xing Huang
Matched on ORCID iD 0000-0002-2875-9444; OpenAlex author ID A5101684746. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 2 papers
Papers 5
- LncRNA VASH1 antisense RNA 1/miR-199a-5p/Programmed Cell Death 4 Axis Regulate Proliferation, Apoptosis, and Cell Cycle in Pancreatic Ductal Adenocarcinoma Pro… Co-author DOI 10.1166/jbn.2024.3834↗
- Flubendazole presents anti-tumor effects by promoting cell cycle arrest and inhibiting the invadopodia in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-4570726/v1↗
- Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway. First author DOI 10.1016/j.tice.2022.101787↗
- Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. Co-author DOI 10.1080/21655979.2021.2016326↗
- Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer. Co-author DOI 10.2147/dddt.s261017↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bole Tian · 2 shared papers, 2024 · strength 0.57
- Paper LncRNA VASH1 antisense RNA 1/miR-199a-5p/Programmed Cell Death 4 Axis Regulate Proliferation, Apoptosis, and Cell Cycle… DOI 10.1166/jbn.2024.3834↗
- Paper Flubendazole presents anti-tumor effects by promoting cell cycle arrest and inhibiting the invadopodia in pancreatic ca… DOI 10.21203/rs.3.rs-4570726/v1↗
- Zihe Wang · 2 shared papers, 2022–2024 · strength 0.43
- Paper Flubendazole presents anti-tumor effects by promoting cell cycle arrest and inhibiting the invadopodia in pancreatic ca… DOI 10.21203/rs.3.rs-4570726/v1↗
- Paper Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. DOI 10.1080/21655979.2021.2016326↗
- Zhenlu Li · 2 shared papers, 2022 · strength 0.40
- Paper Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by … DOI 10.1016/j.tice.2022.101787↗
- Paper Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis. DOI 10.1080/21655979.2021.2016326↗
- Wei Liu · 1 shared paper, 2024 · strength 0.31
- Xiao Tan · 1 shared paper, 2024 · strength 0.31
- Pengcheng Zhao · 1 shared paper, 2024 · strength 0.26
- Kang Xue · 1 shared paper, 2024 · strength 0.26
- Weiming Hu · 1 shared paper, 2022 · strength 0.22
- Huimin Lü · 1 shared paper, 2022 · strength 0.22
- Weiming Hu · 1 shared paper, 2022 · strength 0.17
- Huimin Lu · 1 shared paper, 2022 · strength 0.17
- Chen Yang · 1 shared paper, 2020 · strength 0.11
- Yi Zhang · 1 shared paper, 2020 · strength 0.11
- Chao Wu · 1 shared paper, 2020 · strength 0.11
- Li Wang · 1 shared paper, 2020 · strength 0.11
- Bole Tian · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.